Cancer: Vaccination

(asked on 20th January 2021) - View Source

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment and research they have undertaken in support of advice or guidance for (1) the treatment of, (2) evaluating the risk of, and (3) recommending the most effective vaccine for, Follicular Lymphoma.


Answered by
Lord Bethell Portrait
Lord Bethell
This question was answered on 31st March 2021

In 2016, the National Institute for Health and Care Excellence (NICE) published the guideline Non-Hodgkin’s lymphoma: diagnosis and management. The guideline covers diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years old and over. The guideline includes specific recommendations related to the management and treatment of different stages of follicular lymphoma. A copy of the guideline is attached.

UK Research and Innovation is funding research on vaccine responses in groups of immune-supressed individual as part of its support for the OCTAVE study in the National Core Studies (NCS) Immunity Programme. The NCS Immunity Programme was established in October 2020 to enable the United Kingdom to use health data and research at scale, recognising the need to respond to near term strategic, policy and operational pressures and ultimately maintain resilience against COVID-19.

Reticulating Splines